MACK [NASD]
Merrimack Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.14 Insider Own1.09% Shs Outstand13.41M Perf Week4.95%
Market Cap71.07M Forward P/E- EPS next Y- Insider Trans180.71% Shs Float13.26M Perf Month-4.93%
Income-1.90M PEG- EPS next Q- Inst Own64.20% Short Float2.05% Perf Quarter-17.83%
Sales- P/S- EPS this Y19.10% Inst Trans4.94% Short Ratio15.64 Perf Half Y27.40%
Book/sh1.05 P/B5.05 EPS next Y- ROA-12.50% Target Price4.00 Perf Year-16.54%
Cash/sh1.07 P/C4.97 EPS next 5Y5.60% ROE-13.00% 52W Range3.66 - 7.41 Perf YTD35.55%
Dividend- P/FCF- EPS past 5Y56.90% ROI- 52W High-28.48% Beta1.67
Dividend %- Quick Ratio25.90 Sales past 5Y- Gross Margin- 52W Low44.81% ATR0.34
Employees- Current Ratio25.90 Sales Q/Q- Oper. Margin- RSI (14)46.11 Volatility8.20% 5.84%
OptionableYes Debt/Eq0.00 EPS Q/Q81.10% Profit Margin- Rel Volume0.08 Prev Close5.13
ShortableYes LT Debt/Eq0.00 EarningsMay 05 AMC Payout- Avg Volume17.36K Price5.30
Recom3.50 SMA20-0.94% SMA50-10.01% SMA2004.91% Volume1,472 Change3.31%
Oct-07-16Downgrade JP Morgan Overweight → Neutral
May-27-16Initiated Robert W. Baird Neutral $8
Dec-23-15Reiterated Mizuho Buy $16 → $13
Oct-27-15Reiterated Oppenheimer Outperform $13 → $15
Apr-21-15Reiterated Mizuho Buy $13 → $16
Oct-10-14Resumed Oppenheimer Outperform $9 → $11
Jul-08-14Resumed Brean Capital Buy $16
Jun-20-14Reiterated Oppenheimer Outperform $10 → $8.50
Aug-09-13Reiterated Oppenheimer Outperform $12 → $10
Jun-25-13Initiated Mizuho Buy $12
May-08-12Initiated Oppenheimer Outperform $12
May-05-22 04:30PM  
Mar-09-22 04:30PM  
Jan-27-22 04:48AM  
Dec-06-21 07:22AM  
Nov-04-21 05:00PM  
Sep-06-21 09:50AM  
Aug-05-21 04:30PM  
Jun-08-21 05:31AM  
Jun-07-21 02:10PM  
May-28-21 08:00AM  
Mar-10-21 06:00PM  
Dec-10-20 02:10AM  
Dec-03-20 07:46AM  
Nov-29-20 12:12PM  
Nov-05-20 08:20AM  
Aug-07-20 08:20AM  
Aug-05-20 08:33AM  
May-07-20 06:10PM  
Apr-02-20 08:30AM  
Feb-07-20 11:14AM  
Dec-22-19 07:44PM  
Dec-03-19 09:15AM  
08:45AM  
Oct-28-19 06:04AM  
Sep-24-19 04:45PM  
Sep-19-19 03:23PM  
09:00AM  
Aug-26-19 11:27AM  
09:00AM  
Aug-22-19 08:30AM  
Aug-16-19 09:15AM  
Jul-25-19 08:30AM  
May-31-19 07:34AM  
06:21AM  
May-30-19 04:05PM  
May-10-19 07:30AM  
May-06-19 01:46PM  
May-03-19 05:43PM  
Apr-18-19 03:07PM  
Apr-16-19 04:15PM  
Apr-12-19 01:57PM  
Apr-09-19 05:50PM  
Apr-08-19 10:12AM  
Apr-05-19 08:29AM  
07:48AM  
Apr-04-19 05:58PM  
04:15PM  
Mar-07-19 09:06AM  
Mar-06-19 07:00AM  
Feb-12-19 07:35AM  
Feb-11-19 09:39AM  
Jan-28-19 10:19PM  
Dec-10-18 05:00PM  
Nov-09-18 10:31AM  
08:45AM  
Nov-08-18 10:17AM  
Nov-07-18 06:45AM  
Nov-06-18 01:44PM  
Nov-05-18 07:55AM  
Oct-31-18 04:05PM  
Oct-24-18 11:19AM  
Oct-19-18 10:48AM  
07:46AM  
06:00AM  
Oct-16-18 07:30AM  
Oct-11-18 05:16PM  
Sep-20-18 07:00AM  
Sep-06-18 10:35AM  
06:50AM  
Sep-05-18 12:06PM  
Sep-04-18 10:07AM  
Aug-16-18 08:00AM  
Aug-08-18 10:20AM  
Aug-07-18 08:18AM  
06:30AM  
06:30AM  
Aug-01-18 12:09PM  
Jul-31-18 04:10PM  
Jul-10-18 04:55PM  
Jul-02-18 04:15PM  
Jun-27-18 08:12AM  
Jun-26-18 07:51PM  
08:12AM  
Jun-25-18 07:55AM  
07:54AM  
07:29AM  
07:20AM  
Jun-15-18 08:41AM  
Jun-07-18 09:15AM  
Jun-04-18 01:57PM  
May-29-18 08:15AM  
07:00AM  
May-09-18 10:49AM  
May-08-18 06:25AM  
May-03-18 10:13AM  
May-01-18 07:00AM  
Apr-09-18 07:30AM  
Apr-04-18 08:15AM  
Mar-14-18 07:30AM  
Mar-13-18 09:45AM  
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CROCKER GARY LSee RemarksMay 19Buy5.045122,582123,549May 23 04:05 PM
CROCKER GARY LSee RemarksMay 18Buy5.085,00025,407123,037May 19 04:05 PM
CROCKER GARY LSee RemarksMay 17Buy5.102251,147118,037May 19 04:05 PM
CROCKER GARY LSee RemarksApr 21Buy6.005,00030,001115,338Apr 25 04:05 PM
CROCKER GARY LSee RemarksMar 31Buy6.183001,853110,338Apr 01 04:05 PM
CROCKER GARY LSee RemarksMar 30Buy6.20161998110,038Apr 01 04:05 PM
CROCKER GARY LSee RemarksMar 28Buy6.165,00030,822109,877Mar 29 05:30 PM
CROCKER GARY LSee RemarksMar 22Buy6.114002,446104,877Mar 24 04:05 PM
CROCKER GARY LSee RemarksMar 15Buy6.144,64928,556104,477Mar 17 04:05 PM
CROCKER GARY LSee RemarksMar 14Buy6.025,00030,12099,828Mar 15 04:05 PM
CROCKER GARY LSee RemarksMar 11Buy6.085,00030,40694,828Mar 15 04:05 PM
CROCKER GARY LSee RemarksFeb 18Buy5.963,35119,97089,828Feb 23 04:05 PM
CROCKER GARY LSee RemarksFeb 17Buy6.135,00030,62686,477Feb 18 04:05 PM
CROCKER GARY LSee RemarksFeb 16Buy6.207,94549,23181,477Feb 18 04:05 PM
CROCKER GARY LSee RemarksFeb 15Buy6.2012376373,532Feb 16 04:05 PM
CROCKER GARY LSee RemarksFeb 14Buy5.961,80010,72473,409Feb 16 04:05 PM
Levy Noah G.DirectorJan 31Buy5.051,2376,246989,337Feb 01 04:05 PM
Levy Noah G.DirectorJan 28Buy4.4812,96358,033988,623Feb 01 04:05 PM
Levy Noah G.DirectorJan 27Buy4.8216,27278,475712,294Jan 28 04:05 PM
CROCKER GARY LSee RemarksJan 27Buy4.606733,09671,609Jan 31 04:05 PM
CROCKER GARY LSee RemarksJan 26Buy4.563,10014,12170,936Jan 27 04:05 PM
Levy Noah G.DirectorJan 26Buy5.0119,52897,785696,022Jan 28 04:05 PM
Nielsen Ulrik B.DirectorJan 24Buy4.2414,28760,63036,968Jan 25 04:13 PM
CROCKER GARY LSee RemarksJan 24Buy4.337,10530,74167,836Jan 25 04:05 PM
CROCKER GARY LSee RemarksJan 21Buy4.652,0009,31060,731Jan 25 04:05 PM
CROCKER GARY LSee RemarksJan 18Buy4.545,00022,68958,731Jan 20 04:05 PM
CROCKER GARY LSee RemarksJan 14Buy4.515,00022,55453,731Jan 18 04:05 PM
CROCKER GARY LSee RemarksJan 13Buy4.425,00022,12048,731Jan 18 04:05 PM
CROCKER GARY LSee RemarksJan 12Buy4.335,00021,65843,731Jan 13 04:05 PM
CROCKER GARY LSee RemarksJan 11Buy4.035,00020,14038,731Jan 13 04:05 PM
Levy Noah G.DirectorJan 11Buy4.0091,270364,907987,118Jan 12 04:05 PM
Levy Noah G.DirectorJan 10Buy3.8314,67956,285910,576Jan 12 04:05 PM
Levy Noah G.DirectorJan 07Buy3.828,78033,524901,857Jan 10 04:05 PM
RAY RUSSELL TDirectorDec 31Sale3.841,0003,8400Jan 04 04:05 PM